2-Imidazole as a Substitute for the Electrophilic Group Gives Highly Potent Prolyl Oligopeptidase Inhibitors

dc.contributor.authorPätsi Henri T
dc.contributor.authorKilpeläinen Tommi P
dc.contributor.authorAuno Samuli
dc.contributor.authorDillemuth Pyry MJ
dc.contributor.authorArja Khaled
dc.contributor.authorLahtela-Kakkonen Maija K
dc.contributor.authorMyöhänen Timo T
dc.contributor.authorWallén Erik AA
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organization-code2607100
dc.converis.publication-id67752755
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/67752755
dc.date.accessioned2025-08-28T02:16:34Z
dc.date.available2025-08-28T02:16:34Z
dc.description.abstractDifferent five-membered nitrogen-containing heteroaromatics in the position of the typical electrophilic group in prolyl oligopeptidase (PREP) inhibitors were investigated and compared to tetrazole. The 2-imidazoles were highly potent inhibitors of the proteolytic activity. The binding mode for the basic imidazole was studied by molecular docking as it was expected to differ from the acidic tetrazole. A new putative noncovalent binding mode with an interaction to His680 was found for the 2-imidazoles. Inhibition of the proteolytic activity did not correlate with the modulating effect on protein-protein-interaction-derived functions of PREP (i.e., dimerization of alpha-synuclein and autophagy). Among the highly potent PREP inhibiting 2-imidazoles, only one was also a potent modulator of PREP-catalyzed alpha-synuclein dimerization, indicating that the linker length on the opposite side of the molecule from the five-membered heteroaromatic is critical for the disconnected structure-activity relationships.
dc.format.pagerange1578
dc.format.pagerange1584
dc.identifier.eissn1948-5875
dc.identifier.jour-issn1948-5875
dc.identifier.olddbid208838
dc.identifier.oldhandle10024/191865
dc.identifier.urihttps://www.utupub.fi/handle/11111/33802
dc.identifier.urlhttps://pubs.acs.org/doi/10.1021/acsmedchemlett.1c00399
dc.identifier.urnURN:NBN:fi-fe2021120158484
dc.language.isoen
dc.okm.affiliatedauthorMyöhänen, Timo
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherAmer Chemical Soc
dc.publisher.countryUnited Statesen_GB
dc.publisher.countryYhdysvallat (USA)fi_FI
dc.publisher.country-codeUS
dc.relation.doi10.1021/acsmedchemlett.1c00399
dc.relation.ispartofjournalACS Medicinal Chemistry Letters
dc.relation.issue10
dc.relation.volume12
dc.source.identifierhttps://www.utupub.fi/handle/10024/191865
dc.title2-Imidazole as a Substitute for the Electrophilic Group Gives Highly Potent Prolyl Oligopeptidase Inhibitors
dc.year.issued2021

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
acsmedchemlett.1c00399.pdf
Size:
2.78 MB
Format:
Adobe Portable Document Format
Description:
Publisher's PDF